Standout Papers

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil... 2005 2026 2012 2019 1.5k
  1. Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer (2005)
    William J. Gradishar, Sergei Tjulandin et al. Journal of Clinical Oncology
  2. Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial (2012)
    Mark A. Socinski, Igor Bondarenko et al. Journal of Clinical Oncology

Immediate Impact

11 by Nobel laureates 13 from Science/Nature 131 standout
Sub-graph 1 of 16

Citing Papers

Nanomedicine Tumor Targeting
2024 Standout
Integration of TADF Photosensitizer as “Electron Pump” and BSA as “Electron Reservoir” for Boosting Type I Photodynamic Therapy
2023 Standout
28 intermediate papers

Works of Paul Bhar being referenced

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
2012 Standout
Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
2006
and 3 more

Author Peers

Author Last Decade Papers Cites
Paul Bhar 2103 816 605 1023 33 3.5k
D G Kieback 1558 667 375 637 54 3.3k
Leila Alland 2060 383 450 669 39 4.9k
Mary Jo Turk 2189 362 239 682 62 5.6k
Andreas Wicki 1455 426 427 1107 81 4.5k
Neville Davidson 3634 1151 779 584 25 4.9k
Vuong Trieu 1902 561 861 928 84 3.9k
Tamar Safra 3954 578 628 944 97 6.6k
Noe Kyeong Kim 1701 1364 362 457 58 3.3k
Margareta M. Mueller 1704 377 1008 342 48 4.5k
Barbara Haley 1697 614 893 387 54 2.8k

All Works

Loading papers...

Rankless by CCL
2026